Filters

Anti-Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99 (Recombinant)

Anti-Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99 (Recombinant) size: 2 µg 238

Supplier ABBEX
Price 238
Size 2 µg
CategoryProteins And Peptides
TargetInfluenza A Virus H1N1 New Caledonia 20/99
ImmunogenSee techfile
Reactivity Mouse, Rat, Human
FormUnconjugated
PurificationAffinity purified
ApplicationsWB (for other see techfile or inquire)
Stock availabilityShipped within 5-10 working days
Storage conditions Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C
WarningsThis product is for research use only
Description Influenza is an , The cough, These symptoms typically begin two days after exposure to the virus and most last less than a week, and , but these are not common in adults, however, may last for more than two weeks, peptides and antibodies detect a virus commonly known as ", there may be ,  ,  ,  ,  ,  ,  ,  ,  , In children, Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, Symptoms can be mild to severe, The most common , and , caused by an , coughing, feeling tired, fever, flu", headache, infectious disease , influenza virus, muscle pains, nausea , runny nose, sore throat, symptoms include a high , the , vomiting
Source proteins, Recombinants or rec
Grouprecombinants
Gene targetHemagglutinin-Influenza A Virus H1N1 New Caledonia 20/
Short nameAnti-Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99 (Recombinant)
Technique E, abbex advises they will be reconstituted in a buffer soluion or culture medium for cell culture, coli recombinant proteins are , supplied as white sterile powder lyopillized, Recombinant, genetic recombinations , in Escherichia coli
Species Influenza, Viruses, Virus
Alternative nameantibody to-Hemagglutinin-Influenza A Virus H1N1 New Caledonia 20/99 (recombinant)
Alternative techniquerec

Similar products

Subscribe to our Newsletter